BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 12520709)

  • 41. [Quantification of PML/RAR alpha fusion gene transcripts in patients with acute promyelocytic leukemia by using real-time quantitative PCR].
    Lin J; Han LX; Qian J; Wang YL; Qian Z; Yang XF; Sheng XJ
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2008 Jun; 25(3):319-21. PubMed ID: 18543226
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Variant acute promyelocytic leukemia translocation (15;17) originating from two subsequent balanced translocations involving the same chromosomes 15 and 17 while preserving the PML/RARA fusion.
    Tirado CA; Jahn JA; Scheerle J; Eid M; Meister RJ; Christie RJ; Croft CD; Wallingford S; Heritage DW; Mowrey PN; Meloni-Ehrig AM
    Cancer Genet Cytogenet; 2005 Aug; 161(1):70-3. PubMed ID: 16080960
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Detection and quantification of aberrant leukemia fusion gene by real-time RT-PCR].
    Li XJ; Yu MJ; Liang Y; He D; Li B; Hu J; Chen Q; Li HM
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Aug; 17(4):969-73. PubMed ID: 19698240
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Post-PCR multiplex fluorescent ligation detection assay and flow cytometry for rapid detection of gene-specific translocations in leukemia.
    Chen IM; Chakerian A; Combs D; Garner K; Viswanatha DS
    Am J Clin Pathol; 2004 Nov; 122(5):783-93. PubMed ID: 15491975
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Identification of the breakpoints at 1p36.2 and 3p21.3 in an AML(M3) patient who had t(1;3)(p36.2;p21.3) at the third relapse.
    Tri NK; Xinh PT; Nagao H; Izumi T; Ozawa K; Toyoda A; Hattori M; Sakaki Y; Tokunaga K; Sato Y
    Genes Chromosomes Cancer; 2002 Dec; 35(4):365-7. PubMed ID: 12378531
    [TBL] [Abstract][Full Text] [Related]  

  • 46. When can real-time quantitative RT-PCR effectively define molecular relapse in acute promyelocytic leukemia patients? (Results of the French Belgian Swiss APL Group).
    Cassinat B; de Botton S; Kelaidi C; Ades L; Zassadowski F; Guillemot I; Schlageter MH; Raffoux E; Harousseau JL; Legrand O; Escoffre-Barbe M; Reman O; Gardembas M; Himberlin C; Cahn JY; Guyotat D; Bouscary D; Parry A; Rousselot P; Baruchel A; Dombret H; Chevret S; Fenaux P; Chomienne C
    Leuk Res; 2009 Sep; 33(9):1178-82. PubMed ID: 19167754
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A new cytogenetic abnormality, t(2;7)(q33;q36), in acute promyelocytic leukemia.
    Owatari S; Uozumi K; Haraguchi K; Ohno N; Tokunaga M; Tokunaga M; Suzuki S; Hanada S; Arima N
    Cancer Genet Cytogenet; 2007 Feb; 173(1):71-4. PubMed ID: 17284374
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The t(15;17) breakpoint in acute promyelocytic leukemia cluster within two different sites of the myl gene: targets for the detection of minimal residual disease by the polymerase chain reaction.
    Chang KS; Lu JF; Wang G; Trujillo JM; Estey E; Cork A; Chu DT; Freireich EJ; Stass SA
    Blood; 1992 Feb; 79(3):554-8. PubMed ID: 1310060
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A novel cryptic translocation t(12;17)(p13;p12-p13) in a secondary acute myeloid leukemia results in a fusion of the ETV6 gene and the antisense strand of the PER1 gene.
    Murga Penas EM; Cools J; Algenstaedt P; Hinz K; Seeger D; Schafhausen P; Schilling G; Marynen P; Hossfeld DK; Dierlamm J
    Genes Chromosomes Cancer; 2003 May; 37(1):79-83. PubMed ID: 12661008
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Masked t(15;17) APL with the insertion of PML-RARalpha fusion gene in 4q21.
    Haraguchi K; Ohno N; Tokunaga M; Tokunaga M; Itoyama T; Gotoh M; Taniwaki M; Tubouchi H
    Leuk Res; 2009 Nov; 33(11):1552-5. PubMed ID: 19477514
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Two Ph chromosome positive chronic myelogenous leukemia patients with rare bcr/abl fusion gene].
    Qin YZ; Liu YR; Li JL; Wang H; Chang Y; Fu JY; Ruan GR; Shi HL; Qiu JY; Lu DP; Chen SS
    Zhonghua Xue Ye Xue Za Zhi; 2004 Jul; 25(7):409-12. PubMed ID: 15355693
    [TBL] [Abstract][Full Text] [Related]  

  • 52. CD34 expression is associated with poor clinical outcome in patients with acute promyelocytic leukemia.
    Lee JJ; Cho D; Chung IJ; Cho SH; Park KS; Park MR; Ryang DW; Kim HJ
    Am J Hematol; 2003 Jul; 73(3):149-53. PubMed ID: 12827650
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Clinical screening of gene rearrangements in childhood leukemia by using a multiplex polymerase chain reaction-microarray approach.
    Nasedkina TV; Zharinov VS; Isaeva EA; Mityaeva ON; Yurasov RN; Surzhikov SA; Turigin AY; Rubina AY; Karachunskii AI; Gartenhaus RB; Mirzabekov AD
    Clin Cancer Res; 2003 Nov; 9(15):5620-9. PubMed ID: 14654544
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Electrochemical branched-DNA assay for polymerase chain reaction-free detection and quantification of oncogenes in messenger RNA.
    Lee AC; Dai Z; Chen B; Wu H; Wang J; Zhang A; Zhang L; Lim TM; Lin Y
    Anal Chem; 2008 Dec; 80(24):9402-10. PubMed ID: 19007191
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Prognostic value of minimal residual disease quantification by real-time reverse transcriptase polymerase chain reaction in patients with core binding factor leukemias.
    Krauter J; Gorlich K; Ottmann O; Lubbert M; Dohner H; Heit W; Kanz L; Ganser A; Heil G
    J Clin Oncol; 2003 Dec; 21(23):4413-22. PubMed ID: 14645432
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Variability in the levels of PML-RAR alpha fusion transcripts detected by the laboratories participating in an external quality control program using several reverse transcription polymerase chain reaction protocols.
    Bolufer P; Lo Coco F; Grimwade D; Barragán E; Diverio D; Cassinat B; Chomienne C; Gonzalez M; Colomer D; Gomez MT; Marugan I; Román J; Delgado MD; García-Marco JA; Bornstein R; Vizmanos JL; Martinez B; Jansen J; Villegas A; de Blas JM; Cabello P; Sanz MA
    Haematologica; 2001 Jun; 86(6):570-6. PubMed ID: 11418365
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Rapid detection of leukemia-associated translocation fusion genes using a novel combined RT-PCR and flow cytometric method.
    Zhang QY; Garner K; Viswanatha DS
    Leukemia; 2002 Jan; 16(1):144-9. PubMed ID: 11840274
    [TBL] [Abstract][Full Text] [Related]  

  • 58. More on geographic hematology: the breakpoint cluster regions of the PML/RARalpha fusion gene in Mexican Mestizo patients with promyelocytic leukemia are different from those in Caucasians.
    Ruiz-Argüelles GJ; Garcés-Eisele J; Reyes-Núñez V; Gómez-Rangel JD; Ruiz-Delgado GJ
    Leuk Lymphoma; 2004 Jul; 45(7):1365-8. PubMed ID: 15359634
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cloning and characterization of the t(15;17) translocation breakpoint region in acute promyelocytic leukemia.
    Lemons RS; Eilender D; Waldmann RA; Rebentisch M; Frej AK; Ledbetter DH; Willman C; McConnell T; O'Connell P
    Genes Chromosomes Cancer; 1990 Jul; 2(2):79-87. PubMed ID: 2278973
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Simple, rapid and accurate molecular diagnosis of acute promyelocytic leukemia by loop mediated amplification technology.
    Spinelli O; Rambaldi A; Rigo F; Zanghì P; D'Agostini E; Amicarelli G; Colotta F; Divona M; Ciardi C; Coco FL; Minnucci G
    Oncoscience; 2015; 2(1):50-8. PubMed ID: 25815362
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.